Equity and capacity to benefit from early access to medicines schemes
{{output}}
Many diseases, especially rare ones, have not gained the attention or support needed to attract dedicated research interest to be able to develop successful medicines. There is, thus, a significant unmet clinical need, not all of which is (or indeed can be) ad... ...
